190 related articles for article (PubMed ID: 2813667)
1. A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.
Meltzer HY; Bastani B; Kwon KY; Ramirez LF; Burnett S; Sharpe J
Psychopharmacology (Berl); 1989; 99 Suppl():S68-72. PubMed ID: 2813667
[TBL] [Abstract][Full Text] [Related]
2. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.
Meltzer HY; Burnett S; Bastani B; Ramirez LF
Hosp Community Psychiatry; 1990 Aug; 41(8):892-7. PubMed ID: 2401480
[TBL] [Abstract][Full Text] [Related]
3. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
Jalenques I; Coudert AJ
Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
[TBL] [Abstract][Full Text] [Related]
4. [Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].
Jalenques I; Coudert AJ
Encephale; 1994; 20(6):767-75. PubMed ID: 7875111
[TBL] [Abstract][Full Text] [Related]
5. The effects of clozapine on symptom clusters in treatment-refractory patients.
Abraham G; Nair C; Tracy JI; Simpson GM; Josiassen RC
J Clin Psychopharmacol; 1997 Feb; 17(1):49-53. PubMed ID: 9004057
[TBL] [Abstract][Full Text] [Related]
6. Predictors of response to clozapine therapy.
Honigfeld G; Patin J
Psychopharmacology (Berl); 1989; 99 Suppl():S64-7. PubMed ID: 2813666
[TBL] [Abstract][Full Text] [Related]
7. Duration of a clozapine trial in neuroleptic-resistant schizophrenia.
Meltzer HY
Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591
[No Abstract] [Full Text] [Related]
8. Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia.
Suzuki T; Remington G; Arenovich T; Uchida H; Agid O; Graff-Guerrero A; Mamo DC
Br J Psychiatry; 2011 Oct; 199(4):275-80. PubMed ID: 22187729
[TBL] [Abstract][Full Text] [Related]
9. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.
Hagger C; Buckley P; Kenny JT; Friedman L; Ubogy D; Meltzer HY
Biol Psychiatry; 1993 Nov; 34(10):702-12. PubMed ID: 8292674
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
11. Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia.
Friedman L; Knutson L; Shurell M; Meltzer HY
Biol Psychiatry; 1991 May; 29(9):865-77. PubMed ID: 2049485
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients.
Revicki DA; Luce BR; Weschler JM; Brown RE; Adler MA
Hosp Community Psychiatry; 1990 Aug; 41(8):850-4. PubMed ID: 2169457
[No Abstract] [Full Text] [Related]
13. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
Lee J; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
Eur Neuropsychopharmacol; 2014 Oct; 24(10):1622-9. PubMed ID: 25156578
[TBL] [Abstract][Full Text] [Related]
14. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
15. Is clozapine response different in neuroleptic nonresponders vs partial responders?
Osser DN; Albert LG
Arch Gen Psychiatry; 1990 Feb; 47(2):189-90. PubMed ID: 1967927
[No Abstract] [Full Text] [Related]
16. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
[TBL] [Abstract][Full Text] [Related]
17. A review of clozapine: an antipsychotic for treatment-resistant schizophrenia.
Stephens P
Compr Psychiatry; 1990; 31(4):315-26. PubMed ID: 2201482
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome to clozapine treatment in chronic psychiatric inpatients.
Advokat CD; Bertman LJ; Comaty JE
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):1-14. PubMed ID: 10368852
[TBL] [Abstract][Full Text] [Related]
19. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
Pickar D; Bartko JJ
Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
[TBL] [Abstract][Full Text] [Related]
20. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Thompson PA; Buckley PF; Meltzer HY
J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
